Nalls Sherbakoff Group’s Organon & Co OGN Stock Holding History

Nalls Sherbakoff Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53K	Sell	113 -28	-20%	-$335	﹤0.01%	341
2026 Q1	$845	Hold	141	–	–	﹤0.01%	383
2025 Q4	$1.01K	Buy	141 +28	+25%	+$221	﹤0.01%	412
2025 Q3	$1.21K	Hold	113	–	–	﹤0.01%	399
2025 Q2	$1.09K	Hold	113	–	–	﹤0.01%	401
2025 Q1	$1.68K	Buy	+113	New	+$1.74K	﹤0.01%	385
2023 Q4	$1.64K	Hold	114	–	–	﹤0.01%	360
2023 Q3	$1.98K	Hold	114	–	–	﹤0.01%	349
2023 Q2	$2.21K	Hold	114	–	–	﹤0.01%	351
2023 Q1	$2.63K	Buy	+114	New	+$3.06K	﹤0.01%	355

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Nalls Sherbakoff Group's OGN Position: Q2 2026 in Review

Nalls Sherbakoff Group reduced its Organon & Co (OGN) stake by 20% in Q2 2026, selling an estimated $335 and leaving 113 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Nalls Sherbakoff Group first reported a position in OGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.63K in Q1 2023. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Nalls Sherbakoff Group held 113 shares of Organon & Co worth $1.53K as of Q2 2026.
Nalls Sherbakoff Group sold 28 Organon & Co shares in Q2 2026, an estimated $335.
Organon & Co made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #341 holding.
Nalls Sherbakoff Group first reported a position in Organon & Co in Q1 2023 and has held it in 10 quarters since.
Nalls Sherbakoff Group's Organon & Co position peaked at $2.63K in Q1 2023.
634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.